1. United States General Accounting Office. Drug safety: most drugs withdrawn in recent years had greater health risks for women. Washington, DC: Government Publishing Office; 2001.
2. Roth J, Etzioni R, Waters T, Pettinger M, Rossouw J, Anderson G, Chlebowski R, Manson J, Hlatky M, Johnson K. Economic return from the women’s health initiative Estrogen Plus Progestin clinical trial: a modeling study. Ann Intern Med. 2014;160(9):594–602.
3. Cornelison TL, Clayton J. Considering sex as a biological variable in biomedical research. Gend Genome. 2017; 1(2):89–93; Clayton J. Studying both sexes: a guiding principle for biomedicine. FASEB J. 2015;30:1–6.
4. Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature. 2014;505:612–3.
5. Schiebinger L. Has Feminism changed science? Cambridge, MA: Harvard University press; 1999.